Cwa Asset Management Group, LLC Aquestive Therapeutics, Inc. Transaction History

Cwa Asset Management Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$3.29 - $5.21 $45,438 - $71,955	-13,811 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.17 - $6.73 $10,537 - $17,006	2,527 Added 22.39%	13,811 $72,000
Q4 2020 Feb 09, 2021	BUY	$4.65 - $7.79 $52,470 - $87,902	11,284 New	11,284 $60,000
Q3 2020 Nov 13, 2020	SELL	$4.12 - $9.09 $44,290 - $97,717	-10,750 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.84 - $6.44 $19,780 - $69,230	10,750 New	10,750 $52,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $188M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwa Asset Management Group, LLC with notifications on news.